S. Yoon

发表

A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non–small cell lung cancer with EGFR mutation

K. Lim, Hyae-Young Kim, B. Cho, 2022, Cancer.

First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung.

Hyae-Young Kim, J. Ahn, M. Ahn, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.

Ji-Youn Han, Yeon-Su Lee, Sun Hye Kim, 2014, Lung cancer.

Randomized Phase II Study of Maintenance Irinotecan Therapy Versus Observation Following Induction Chemotherapy with Irinotecan and Cisplatin in Extensive Disease Small Cell Lung Cancer

K. Lim, Heung Tae Kim, Dae-Ho Lee, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A Pilot Trial of Gemcitabine and Vinorelbine Plus Capecitabine in Locally Advanced or Metastatic Nonsmall Cell Lung Cancer

Seong Min Yoon, Hyae-Young Kim, Dae-Ho Lee, 2006, American journal of clinical oncology.

Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.

Hyae-Young Kim, Dae-Ho Lee, Ji-Youn Han, 2005, International journal of radiation oncology, biology, physics.

DNA repair gene polymorphisms and benefit from gefitinib in never‐smokers with lung adenocarcinoma

Heung Tae Kim, K. Yoon, Ji-Youn Han, 2011, Cancer.

P2.01-51 Next-Generation Sequencing for Effective Detection of Various EGFR Exon 20 Insertions (E20ins) in Non-Small Cell Lung Cancer (NSCLC)

Dae-Ho Lee, I. Hwang, S. Kim, 2019, Journal of Thoracic Oncology.

Association of SUMO1 and UBC9 genotypes with tumor response in non-small-cell lung cancer treated with irinotecan-based chemotherapy

Heung Tae Kim, Ji-Youn Han, J. S. Lee, 2010, The Pharmacogenomics Journal.

A Phase II Study of Weekly Paclitaxel Plus Gemcitabine as a Second-Line Therapy in Patients with Metastatic or Recurrent Small Cell Lung Cancer

Hyae-Young Kim, Heung Tae Kim, Ji-Youn Han, 2015, Cancer research and treatment : official journal of Korean Cancer Association.

Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole‐brain radiotherapy administered first

Heung Tae Kim, Dae-Ho Lee, Ji-Youn Han, 2008, Cancer.

Laparoscopic Hiatal Hernia Repair and Roux-en-Y Conversion for Refractory Duodenogastroesophageal Reflux after Billroth I Distal Gastrectomy

Jong Won Kim, Joong-Min Park, K. Chi, 2020, Journal of Gastric Cancer.

A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naïve patients with metastatic or recurrent squamous cell carcinoma of the esophagus

Hyae-Young Kim, Heung Tae Kim, Dae-Ho Lee, 2007, Cancer Chemotherapy and Pharmacology.

Ji-Youn Han, Yeon-Su Lee, Sun Hye Kim, 2014, Lung cancer.